SNCA and Parkinson disease: Previously, we have shown that loss of ahr-1 also extends the lifespan in Huntington’s disease and Parkinson’s disease models, with muscle-overexpression of aggregation-prone polyglutamine (polyQ40) and α-synuclein (α-syn), respectively, while at the same time increasing their content of protein aggregates [25].